Screener
ADMA Biologics ADMA EV / EBITDA
EV / EBITDA at other companies
Other financials
Where this comes from
Calculated from ADMA Biologics’s reported figures.
Based on the most recent quarter.
The source filing: ADMA Biologics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:16 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001140361-26-031445
FAQ
- What is ADMA Biologics's EV / EBITDA?
- ADMA Biologics (ADMA) reported EV / EBITDA of 8.7× in Q2 2026.
- How has ADMA Biologics's EV / EBITDA changed year-over-year?
- ADMA Biologics's EV / EBITDA decreased by 66.2% year-over-year, from 25.6× to 8.7×.
- What is the long-term trend for ADMA Biologics's EV / EBITDA?
- Over 2 years (2023 to 2025), ADMA Biologics's EV / EBITDA has grown at a -19.5% compound annual growth rate (CAGR), from 33.6× to 21.7×.
- What does EV / EBITDA mean?
- Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.
Ask your AI about ADMA Biologics's ev / ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude